0001493152-20-000279.txt : 20200106
0001493152-20-000279.hdr.sgml : 20200106
20200106214114
ACCESSION NUMBER: 0001493152-20-000279
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAUM MARK L
CENTRAL INDEX KEY: 0001274282
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 20512003
MAIL ADDRESS:
STREET 1: C/O IMPRIMIS PHARMACEUTICALS, INC
STREET 2: 12264 EL CAMINO REAL, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW HEALTH, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-704-4042
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
4/A
1
ownership.xml
X0306
4/A
2020-01-02
2020-01-06
0
0001360214
HARROW HEALTH, INC.
HROW
0001274282
BAUM MARK L
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD., SUITE 610
NASHVILLE
TN
37205
1
1
0
0
Chief Executive Officer
Option - Right to Buy
7.30
2020-01-02
4
A
0
217500
0.00
A
2030-01-02
Common Stock
217500
217500
D
Restricted Stock Unit
0
2020-01-02
4
A
0
88000
0.00
A
2023-01-02
Common Stock
88000
88000
D
Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period.
Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.
This Form 4 amendment corrects the amount of securities "Acquired" by the reporting person which had been incorrectly described as "Disposed Of" in the originally filed Form 4.
/s/ Mark L. Baum
2020-01-06